UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Total Debt Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual total debt in 2023 was 74.32 Million TWD , up 11.62% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly total debt in 2024 Q2 was 71.29 Million TWD , down -2.09% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported annual total debt of 66.58 Million TWD in 2022, up 208.57% from previous year.
  • UnicoCell Biomed Co., Ltd. reported annual total debt of 21.58 Million TWD in 2021, down -36.59% from previous year.
  • UnicoCell Biomed Co., Ltd. reported quarterly total debt of 72.81 Million TWD for 2024 Q1, down -2.03% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported quarterly total debt of 77.32 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Total Debt of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 74.32 Million TWD 11.62%
2022 66.58 Million TWD 208.57%
2021 21.58 Million TWD -36.59%
2020 34.03 Million TWD 0.0%
2019 - TWD 0.0%

Peer Total Debt Comparison of UnicoCell Biomed Co., Ltd.

Name Total Debt Total Debt Difference
Apex Biotechnology Corp. 180.83 Million TWD 58.896%
Sinphar Pharmaceutical Co.,Ltd. 1.94 Billion TWD 96.179%
Panion & Bf Biotech Inc. 727.83 Million TWD 89.788%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 1.2 Billion TWD 93.853%
GenMont Biotech Incorporation 58.3 Million TWD -27.477%
Abnova (Taiwan) Corporation 7.7 Million TWD -864.547%
Adimmune Corporation 3.14 Billion TWD 97.635%
Tanvex BioPharma, Inc. 1.73 Billion TWD 95.708%
Polaris Group 1.19 Billion TWD 93.796%
Energenesis Biomedical CO.,LTD. - TWD -Infinity%
PELL Bio-Med Technology Co. Ltd. 172.55 Million TWD 56.926%